NCT00288691View on ClinicalTrials.gov

Menorrhagia Study in Women With Treatment-resistant Menorrhagia

PHASE2CompletedINTERVENTIONAL

Enrollment

26

Participants

Timeline

Start Date

November 30, 2001

Study Completion Date

January 31, 2004

Conditions

Menorrhagia

Interventions

DRUG

Asoprisnil (BAY86-5294)

5mg/day

DRUG

Asoprisnil (BAY86-5294)

10mg/day

DRUG

Asoprisnil (BAY86-5294)

25mg/day

DRUG

Placebo

Placebo

Sponsors

Lead Sponsor

All Listed Sponsors

collaborator

TAP Pharmaceutical Products Inc.

INDUSTRY

lead

Bayer

INDUSTRY